Merit Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-13,780
| Closed | -$22K | – | 720 |
|
|
2022
Q3 | $22K | Hold |
13,780
| – | – | ﹤0.01% | 553 |
|
|
2022
Q2 | $28K | Sell |
13,780
-3,900
| -22% | -$7.93K | ﹤0.01% | 546 |
|
|
2022
Q1 | $41K | Hold |
17,680
| – | – | ﹤0.01% | 375 |
|
|
2021
Q4 | $82K | Sell |
17,680
-4,000
| -18% | -$18.6K | 0.01% | 272 |
|
|
2021
Q3 | $165K | Hold |
21,680
| – | – | 0.02% | 258 |
|
|
2021
Q2 | $210K | Buy |
21,680
+1,000
| +5% | +$9.69K | 0.02% | 253 |
|
|
2021
Q1 | $171K | Buy |
20,680
+1,000
| +5% | +$8.27K | 0.02% | 227 |
|
|
2020
Q4 | $134K | Hold |
19,680
| – | – | 0.01% | 207 |
|
|
2020
Q3 | $219K | Buy |
19,680
+5,680
| +41% | +$63.2K | 0.02% | 200 |
|
|
2020
Q2 | $88K | Buy |
+14,000
| New | +$88K | 0.01% | 210 |
|